GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cycloviracin B2

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act1072Cycloviracin B2S. aureus SmithBacteriaMIC (μg/ml)10010.1021/ja036521e
act1088Cycloviracin B2Aspergillus fumigatus IAM 2034BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1064Cycloviracin B2Klebsiella pneumoniae  D11BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1080Cycloviracin B2Micrococcus luteus 1001BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1060Cycloviracin B2HSV-Vero cellvirusPlaque reduction assay\nID50 (μg/mL) \nMTD (μg/mL) 9.3 >20010.1021/ja036521e
act1076Cycloviracin B2S. aureus A15097BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1084Cycloviracin B2Candida albicans IAM 4888BacteriaMIC (μg/ml)6.310.1021/ja036521e
act1068Cycloviracin B2Proteus vulgaris A9436BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1058Cycloviracin B2HSV-Vero cellvirusDye uptake assay\nID50 (μg/mL) \nTD50 (μg/mL)  5.0 >40010.1021/ja036521e
act1078Cycloviracin B2Streptococcus faecalis A9612BacteriaMIC (μg/ml)6.310.1021/ja036521e
act1062Cycloviracin B2Escherichia coli NIHJBacteriaMIC (μg/ml)>10010.1021/ja036521e
act1086Cycloviracin B2Cryptococcus neoformans IAM 4514BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1070Cycloviracin B2Staphylococcus aureus  FDA 209PBacteriaMIC (μg/ml)5010.1021/ja036521e
act1090Cycloviracin B2Trichophyton mentagrophytes D155BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1074Cycloviracin B2S. aureus D136BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1066Cycloviracin B2Pseudomonas aeruginosa A9930BacteriaMIC (μg/ml)>10010.1021/ja036521e
act1082Cycloviracin B2Bacillus subtilis PCI219BacteriaMIC (μg/ml)>10010.1021/ja036521e